In addition, in the population autoantibodies (such as antinuclear antibodies, RF and ACPA) are increasingly prevalent at older age [7, 39–41], whereas within RA patents we observed a higher proportion of ACPA-negative disease at older age. This evidence concerns the gene PRTN3 and rheumatoid arthritis.